Get started
Author

Cecilia M. Bahit

Observed names: C. Bahit, C.M. Bahit, Cecilia Bahit, Cecilia M Bahit, M. Cecilia Bahit
Observed institutions: Hospital Italiano de Buenos Aires, Baim Institute for Clinical Research, Instituto de Neurología Cognitiva, Duke Medical Center, Estudios Clínicos Latinoamérica, Duke Clinical Research Institute
ORCID: 0000-0001-6179-4076
Observed ORCID: 0000-0001-6179-4076
OpenAlex ID: A5074295402
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial
2022 · Javed Butler, Stefan D Anker, et al. · European Heart Journal · 249
Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial
2024 · C Michael Gibson, Danielle Duffy, et al. · European Heart Journal · 31
An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: Rationale and design of the BRIDGE STROKE Trial
2018 · Maria Julia Machline-Carrion, Eliana Vieira Santucci, et al. · American Heart Journal · 15
Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and Hyperkalemia
2024 · Bertram Pitt, Stefan D. Anker, et al. · Journal of the American College of Cardiology · 12
Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes
2004 · O. Bazzino, J.J. Fuselli, et al. · ACC Current Journal Review · 10
A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale
2016 · Meena P. Rao, Andrea O. Ciobanu, et al. · American Heart Journal · 9
Age, sex, and setting in the etiology of stroke study (ASSESS): Study design and protocol
2019 · Mahmoud Reza Azarpazhooh, Jennifer L. Mandzia, et al. · Journal of the Neurological Sciences · 6
PDF
Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF)
2017 · Dragos Vinereanu, Hussein R. Al-Khalidi, et al. · American Heart Journal · 6
Abstract 4147550: Evaluating the Clinical Reasoning of GPT-4, Grok, and Gemini in Different Fields of Cardiology
2024 · Jonathan Reyes-Rivera, Alberto Castro Molina, et al. · Circulation · 4
Cardiovascular clinical research in South America
2013 · José C. Nicolau, Ramon Corbalan, et al. · American Heart Journal · 3
Patients with atrial fibrillation treated with apixaban are less likely to discontinue study drug when compared with warfarin : insights from the ARISTOTLE trial
2016 · D. Xavier, Michael G. Hanna, et al. · 2
Targeted statin and antiplatelet therapy in women with high-risk cardiovascular disease: how can we overcome sex-based differences?
2026 · Sebastián Garcia-Zamora, M. Cecilia Bahit · Expert Review of Cardiovascular Therapy
PDF
Abstract 14710: The Landscape of Pharmacological Interventional Trials for the Treatment or Prevention of Coronary Artery Disease: Analysis of clinicaltrials.gov Listings From 2008 to 2022
2023 · Gerald Chi, Cecilia Bahit, et al. · Circulation
Abstract 15497: Association of Blood Cell-Based Inflammatory Markers and C-Reactive Protein With Mortality in Acute Coronary Syndrome Patients: Analysis From the ATLAS ACS-TIMI 46 Trial
2023 · Gerald Chi, Ginger Jiang, et al. · Circulation
[MANAGEMENT RECOMMENDATIONS FOR DIRECT ORAL ANTICOAGULANTS (DOACs) ANTI Xa AND ANTI IIa].
2022 · José M Ceresetto, Carlos Tajer, et al. · PubMed
P3631Determinants of antithrombotic treatment of patients with AF: baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with AF (IMPACT-AF)
2017 · D. Vinereanu, H.R. Al-Khalidi, et al. · European Heart Journal
Anticoagulación en la fibrilación auricular en la Argentina: progreso y oportunidad
2015 · M. Cecilia Bahit, Christopher Granger · Revista Argentina de Cardiología
PDF
Anticoagulation for Atrial Fibrillation in Argentina: Progress and Opportunity
2015 · M. Cecilia Bahit, Christopher Granger · Revista Argentina de Cardiología
PDF
Abstract W P147: Apixaban Versus Warfarin in Patients with Atrial Fibrillation: Patient Characteristics of the Latin America Cohort from a Multinational Clinical Trial
2015 · Alvaro Avezum, Cecilia M Bahit, et al. · Stroke
Usefulness of myocardial viability tests in the decision making process to indicate revascularization in patients with left ventricular dysfunction and coronary artery disease
2013 · A. Orlandini, N. Castellana, et al. · European Heart Journal
Efficacy and Safety of Apixaban in Patients With Atrial Fibrillation According to Sex : Results From the ARISTOTLE Trial
2013 · Dragoş Vinereanu, Susanna R. Stevens, et al. · Circulation
Efficacy and Safety of Apixaban Compared With Warfarin According to Chads2 and Hasbled Risk Scores for Stroke Prevention in Atrial Fibrillation
2012 · Renato D. Lopes, Sana Al-Khatib, et al. · Journal of the American College of Cardiology
PDF
1042-87 White blood cell count predicts angiographic findings in patients with acute coronary syndromes
2004 · Jose L Navarro Estrada, Alfredo Hirschson Prado, et al. · Journal of the American College of Cardiology
PDF
Works count: 23
Citation count: 347
H-index: 6
I10-index: 5
Year
Topic
Type